2 results

  • benefix

    (coagulation factor ix (recombinant))
    Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
    BeneFIX® is indicated for adults and children with hemophilia B for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce bleeding frequency. It is not intended for immune tolerance induction in hemophilia B patients.

  • xyntha

    (antihemophilic factor (recombinant))
    Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
    XYNTHA is indicated for treating and controlling bleeding episodes in adults and children with hemophilia A, managing perioperative care, and routine prophylaxis to reduce bleeding frequency. It is not suitable for patients with von Willebrand's disease as it does not contain von Willebrand factor.